Carlos von Bonhorst
Director/Board Member at EUROCINE VACCINES AB
Carlos von Bonhorst active positions
Companies | Position | Start | End |
---|---|---|---|
EUROCINE VACCINES AB | Director/Board Member | 2022-11-30 | - |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Consultant / Advisor | 2022-03-31 | - |
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Consultant / Advisor | 2021-07-31 | - |
AAAS Fellowship Programs, Inc.
AAAS Fellowship Programs, Inc. Insurance Brokers/ServicesFinance AAAS Fellowship Programs, Inc. provides health insurance services. The company is headquartered in Washington, DC. | Corporate Officer/Principal | 2015-04-30 | - |
European Innovation Council | Corporate Officer/Principal | 2022-02-28 | - |
Career history of Carlos von Bonhorst
Former positions of Carlos von Bonhorst
Companies | Position | Start | End |
---|---|---|---|
National Centre For Research & Development /Poland/
National Centre For Research & Development /Poland/ Miscellaneous Commercial ServicesCommercial Services The National Centre for Research and Development in Poland provides executive agency services. | Corporate Officer/Principal | 2016-12-31 | 2021-10-30 |
RECIPHARM AB (PUBL) | Director/Board Member | 2015-04-30 | 2021-03-30 |
Helsinn Healthcare SA /Venture/
Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Private Equity Investor | 1985-09-30 | 1993-12-30 |
Laboratorios Biofarma SA | Sales & Marketing | 1974-12-31 | 1985-12-30 |
Training of Carlos von Bonhorst
University of Lisbon | Doctorate Degree |
Statistics
International
Sweden | 3 |
United Kingdom | 2 |
Portugal | 2 |
Operational
Corporate Officer/Principal | 3 |
Consultant / Advisor | 2 |
Director/Board Member | 2 |
Sectoral
Finance | 4 |
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
EUROCINE VACCINES AB | Health Technology |
Private companies | 8 |
---|---|
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Finance |
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Health Technology |
AAAS Fellowship Programs, Inc.
AAAS Fellowship Programs, Inc. Insurance Brokers/ServicesFinance AAAS Fellowship Programs, Inc. provides health insurance services. The company is headquartered in Washington, DC. | Finance |
National Centre For Research & Development /Poland/
National Centre For Research & Development /Poland/ Miscellaneous Commercial ServicesCommercial Services The National Centre for Research and Development in Poland provides executive agency services. | Commercial Services |
Recipharm AB
Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
Helsinn Healthcare SA /Venture/
Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Finance |
Laboratorios Biofarma SA | |
European Innovation Council |
- Stock Market
- Insiders
- Carlos von Bonhorst
- Experience